Hashtag
Times Advertising

MINJUVI® (tafasitamab) for Relapsed or Refractory Follicular Lymphoma Approved in Australia

MINJUVI® (tafasitamab) for Relapsed or Refractory Follicular Lymphoma Approved in Australia
  • Minjuvi® (tafasitamab), in combination with rituximab and lenalidomide, is the first and only chemotherapy-free CD19 and CD20 dual-targeted immunotherapy combination regimen to be approved in Australia for adults with relapsed or refractory follicular lymphoma (R/R FL) (Grade 1-3a).1,2
  • Despite the availability of existing treatments, R/R FL...

Read more: MINJUVI® (tafasitamab) for Relapsed or Refractory Follicular Lymphoma Approved in Australia

Health & Wellness

Why An Emergency Dental Clinic Melbourne Is Essential For Immediate Dental Care

Hashtag.net.au - avatar Hashtag.net.au

Dental emergencies rarely arrive with a polite warning. They burst in like an unexpected storm, bringing pain, discomfort, and urgency. In such moments, having access to a reliable emergency dental ...

Specialist Disability Accommodation Explained: What It Is, Who Qualifies, and How to Access It in Perth

Hashtag.net.au - avatar Hashtag.net.au

For many Australians living with significant disability, the question of where to live — and how to live there safely and comfortably — is one of the most important and most complex they will ever f...

How Smart Site Managers Source Wholesale Medical Supplies to Keep Their Teams Safe and Compliant

Hashtag.net.au - avatar Hashtag.net.au

If you're running a construction site, a civil project, or a trade-based operation anywhere in Australia, first aid preparedness probably sits somewhere near the bottom of your planning checklist — ...